Cambrian Biopharma
Cambrian Biopharma is a New York-based, clinical-stage drug development company developing treatments for age-related diseases to create preventive therapies to extend the human health span and improve the quality of life in old age.
1
Funding Rounds
$100.0m
Money raised
Overview
Cambrian Biopharma is a New York-based, clinical-stage drug development company developing treatments for age-related diseases to create preventive therapies to extend the human health span and improve the quality of life in old age.
| Name | Phone | Social networks | |
|---|---|---|---|
| Pa** Fa** | - | - | |
| Ja*** Pe*** | - | - | linkedin twitter |
| Se******* Br******** | - | - | |
| Ch******* An******** | - | - |
| Name | Phone | Social networks | |
|---|---|---|---|
| Pa** Fa** | - | - | |
| St*** Ju******* | - | - | linkedin twitter facebook instagram |
| Ch******* An******** | - | - | linkedin twitter instagram |
| R. Ma**** Ch**** | - | - | |
| Br***** L. Sa****** | - | - | linkedin twitter instagram |
| Ma****** Sa**** | - | - | linkedin twitter facebook instagram |
Funding series
Funding Series Analysis
The company Cambrian Biopharma has raised a total of $100m in funding over 1 rounds.
Key Insights:
- Cambrian Biopharma Series C round, October 2021: $100m
Cambrian Biopharma Series C round, October 2021
$100m
Industries
Cambrian Biopharma is active in the following industries:
- Biotechnology
- Technology
- Biology